54176-51-1

Basic information

• Product Name: 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, dimethyl ester
• Synonyms: 1,3-Benzenedicarboxylic acid,5-bromo-4-hydroxy-,dimethyl ester;5-bromo-4-hydroxy-isophthalic acid dimethyl ester;5-Brom-4-hydroxy-isophthalsaeure-dimethylester
• CAS NO: 54176-51-1
• Molecular Formula: C10H9BrO5
• Molecular Weight: 289.082
• Mol File: 54176-51-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, dimethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, dimethyl ester(54176-51-1)
• EPA Substance Registry System: 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, dimethyl ester(54176-51-1)

Safety Data

• Hazardous Substances Data: 54176-51-1(Hazardous Substances Data)

Upstream product

• 34133-58-9 4-hydroxy-isophthalonitrile 
• 619-72-7 4-nitrobenzonitrile 
• 636-46-4 4-hydroxyisophthalic acid 
• 5985-24-0 dimethyl 4-hydroxyisophthalate 

Downstream Products

• 95088-64-5 3-bromo-2-hydroxy-5-(methoxycarbonyl)benzoic acid 
• 1342299-76-6 C₁₆H₁₃BrO₅ 
• 1342299-77-7 C₁₉H₁₇BrO₅ 
• 1342299-78-8 C₁₈H₁₆O₅ 
• 1342299-79-9 C₂₁H₂₀O₅ 
• 1342299-80-2 C₁₉H₁₆O₅ 
• 1342299-85-7 C₁₈H₁₅BrO₆ 
• 1342299-86-8 C₂₁H₂₀O₆ 
• 5383-97-1 5-Allyl-4-hydroxy-isophthalsaeure-dimethylester 
• 13253-23-1 3-Carboxy-4-hydroxy-5-allyl-benzoesaeure-methylester 
• 1342299-87-9 C₁₉H₁₈O₅ 
• 1342299-88-0 C₂₂H₂₂O₅ 
• 883241-40-5 5-bromo-4-methoxymethoxyisophthalic acid dimethyl ester 
• 98589-65-2 4-methoxy-5-nitro-isophthalic acid 

Relevant articles and documents

WDR5 INHIBITORS AND MODULATORS

Quinazolin-4(3H)-one, 2,3 -dihydroquinazolin-4(1H)-one, 3,4-dihydrobenzo[f][1,4]oxazepin- 5(2H)-one, and 3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione compounds and derivatives inhibit WDR5 and associated protein-protein interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.

COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

The invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease.